circMYC is an oncogene in NPC cells and can enhance the radiotherapy resistance of NPC cells. Circulating exosomal circMYC can be used as a potential therapeutic target for NPC.
Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma.